In addition, in vitro and in vivo murine studies have shown that zinc supplementation downregulates the HIF-1 activity and restores the cancer cell response to therapies through the re-establishment of the HIPK2/p53 apoptotic axis [71,72,98]. Here, HIPK2 is linked to cancer.